Last reviewed · How we verify

Corvert — Competitive Intelligence Brief

Corvert (IBUTILIDE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antiarrhythmic. Area: Cardiovascular.

marketed Antiarrhythmic Potassium voltage-gated channel subfamily H member 2 Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Corvert (IBUTILIDE) — Pfizer.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Corvert TARGET IBUTILIDE Pfizer marketed Antiarrhythmic Potassium voltage-gated channel subfamily H member 2 1995-01-01
Rukobia FOSTEMSAVIR GSK marketed Potassium voltage-gated channel subfamily H member 2 2020-01-01
Daklinza DACLATASVIR Bristol-Myers Squibb marketed Hepatitis C Virus NS5A Inhibitor Potassium voltage-gated channel subfamily H member 2 2015-01-01
Sirturo bedaquiline Janssen Therap marketed Diarylquinoline Antimycobacterial Potassium voltage-gated channel subfamily H member 2 2012-01-01
Invega Sustenna PALIPERIDONE PALMITATE Johnson & Johnson marketed Atypical Antipsychotic Potassium voltage-gated channel subfamily H member 2 2009-01-01
Coartem LUMEFANTRINE Novartis marketed Antimalarial [EPC] Potassium voltage-gated channel subfamily H member 2 2009-01-01
Ketek TELITHROMYCIN Sanofi marketed Ketolide Antibacterial Potassium voltage-gated channel subfamily H member 2 2004-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antiarrhythmic class)

  1. Pfizer · 3 drugs in this class
  2. National Taiwan University Hospital · 2 drugs in this class
  3. Boehringer Ingelheim · 1 drug in this class
  4. Cliniques universitaires Saint-Luc- Université Catholique de Louvain · 1 drug in this class
  5. Eli Lilly · 1 drug in this class
  6. MTI Medical Private Limited, Pakistan · 1 drug in this class
  7. Technical University of Munich · 1 drug in this class
  8. · 1 drug in this class
  9. Wyeth is now a wholly owned subsidiary of Pfizer · 1 drug in this class
  10. Ain Shams University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Corvert — Competitive Intelligence Brief. https://druglandscape.com/ci/ibutilide. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: